Metabolomic Diagnostics

📍 Little Island, Ireland🗓 Founded 2011👥 11 employees💰 Last funded Jan 2024
Biotechnology Research🌐 metabolomicdiagnostics.com
Website LinkedIn
Metabolomic Diagnostics is a deep-tech company specialised in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory. Metabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy, her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Metabolomic Diagnostics?
Metabolomic Diagnostics has 1 investors on record on gritt.io.
When did Metabolomic Diagnostics last raise funding?
The most recent investment in Metabolomic Diagnostics recorded on gritt.io was in January 2024.
When was Metabolomic Diagnostics founded?
Metabolomic Diagnostics was founded in 2011.
What industry is Metabolomic Diagnostics in?
Metabolomic Diagnostics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Metabolomic Diagnostics based?
Metabolomic Diagnostics is headquartered in Little Island, Ireland.